Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparison of the Relative Oral Bioavailability of GKT137831 Formulated in Capsules or in Tablets and Evaluation of the Potential Impact of Concomitant Food Intake on the Relative Bioavailability of GKT137831 in Healthy Male Subjects

Trial Profile

Comparison of the Relative Oral Bioavailability of GKT137831 Formulated in Capsules or in Tablets and Evaluation of the Potential Impact of Concomitant Food Intake on the Relative Bioavailability of GKT137831 in Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Feb 2019

At a glance

  • Drugs GKT 831 (Primary)
  • Indications Bile duct diseases; Diabetic nephropathies
  • Focus Pharmacokinetics
  • Sponsors GenKyoTex
  • Most Recent Events

    • 11 Feb 2019 Status changed from recruiting to completed.
    • 29 Jan 2019 Status changed from not yet recruiting to recruiting.
    • 21 Nov 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top